↓ Skip to main content

Cochrane Database of Systematic Reviews

Azithromycin for acute lower respiratory tract infections

Overview of attention for article published in Cochrane database of systematic reviews, March 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 X users
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
182 Mendeley
Title
Azithromycin for acute lower respiratory tract infections
Published in
Cochrane database of systematic reviews, March 2015
DOI 10.1002/14651858.cd001954.pub4
Pubmed ID
Authors

Malinee Laopaiboon, Ratana Panpanich, Kyaw Swa Mya

Abstract

Acute lower respiratory tract infections (LRTI) range from acute bronchitis and acute exacerbations of chronic bronchitis to pneumonia. Approximately five million people die from acute respiratory tract infections annually. Among these, pneumonia represents the most frequent cause of mortality, hospitalisation and medical consultation. Azithromycin is a macrolide antibiotic, structurally modified from erythromycin and noted for its activity against some gram-negative organisms associated with respiratory tract infections, particularly Haemophilus influenzae (H. influenzae).

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Brazil 1 <1%
Unknown 180 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 14%
Student > Bachelor 22 12%
Researcher 16 9%
Other 13 7%
Student > Postgraduate 10 5%
Other 33 18%
Unknown 62 34%
Readers by discipline Count As %
Medicine and Dentistry 67 37%
Nursing and Health Professions 14 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Biochemistry, Genetics and Molecular Biology 4 2%
Immunology and Microbiology 4 2%
Other 19 10%
Unknown 65 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2022.
All research outputs
#4,680,617
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,852
of 11,842 outputs
Outputs of similar age
#53,668
of 274,251 outputs
Outputs of similar age from Cochrane database of systematic reviews
#147
of 285 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,251 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 285 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.